Quantcast
Last updated on April 24, 2014 at 13:22 EDT

Latest Sequenom Inc. Stories

2014-04-17 08:27:51

SAN DIEGO, April 17, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the first quarter of 2014 after closing of the NASDAQ Global Market on Thursday, May 1, 2014. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm EDT (2:00 pm...

2014-03-21 16:23:33

SAN DIEGO, March 21, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a resolution of litigation between the Company and Paul Hawran. Mr. Hawran served as the Company's Chief Financial Officer from April 2007 until September 2009. Mr. Hawran resigned in September 2009. After September 2009, the Securities and Exchange Commission conducted an investigation concerning...

2014-03-19 04:21:22

DUBLIN, March 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tdmwb8/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Report" [http://www.researchandmarkets.com/research/tdmwb8/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal testing is increasingly being adopted by high risk pregnant women for the...

2014-03-05 20:21:18

Harry Hixson to Retire as Sequenom CEO SAN DIEGO, March 5, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that Harry F. Hixson, Jr., Ph.D., will retire as Chief Executive Officer (CEO), effective as of the Company's 2014 Annual Meeting on June 10, 2014. William J. Welch, the Company's current President and Chief Operating Officer, will assume the role of...

2014-03-03 08:30:45

SAN DIEGO, March 3, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the 26(th) Annual Roth Conference at the Ritz Carlton in Dana Point, CA on March 9-12, 2014. William Welch, President and Chief Operating Officer, and Carolyn D. Beaver, Vice President and Chief Accounting Officer, will present on Tuesday, March 11, beginning at...

2014-02-27 16:28:32

Record Quarterly and Annual Revenues; Annual Growth of 81% Over Prior Year SAN DIEGO, Feb. 27, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today reported total revenues of $45.1 million for the fourth quarter and $162.4 million for the full year of 2013. Net loss was $18.9 million, or $0.16 per share, for the fourth quarter and $107.4 million, or $0.93 per share, for the full year. Recent Key...

2014-02-13 08:30:15

SAN DIEGO, Feb. 13, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the fourth quarter and full year of 2013 after closing of the NASDAQ Global Market on Thursday, February 27, 2014. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at...

2014-01-16 20:22:14

Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk of progressing to late-stage or "wet" age-related macular degeneration (AMD) SOPHIA ANTIPOLIS, France and SAN DIEGO, Jan. 16, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), and Sequenom, Inc. (NASDAQ:SQNM), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an...

2014-01-16 16:24:23

DUBLIN, January 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/322q6g/noninvasive) has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/322q6g/noninvasive ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Non-invasive prenatal...

2014-01-14 16:26:12

SAN DIEGO, Jan. 14, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, entered into an agreement to offer access to its MaterniT21(TM) PLUS laboratory-developed test to Mayo Medical Laboratories. "We are delighted to expand our offerings to our national clients to offer the MaterniT21 PLUS test to physicians who have patients who...